Found 0 matching trials
Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma PHASE3 The goal of this clinical study is test how well the study drug, axicabtage...
Show More Status
Active Not Recruiting
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Learn More & Join Trial
Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or Younger PHASE2 The overall goal of this clinical research study was to find out which of t...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL PHASE2 The purpose of this study is to test the effectiveness and safety of polatu...
Show More Status
Active Not Recruiting
Location
University of Rochester
Learn More & Join Trial
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma PHASE3 This randomized phase III trial studies rituximab when given together with ...
Show More Location
Rebecca and John Moores UCSD Cancer Center
Learn More & Join Trial
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma PHASE3 The purpose of this study is to evaluate the efficacy and safety of PCI-327...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) PHASE3 The purpose of this study is to assess whether copanlisib in combination wi...
Show More Location
Ironwood Physicians P.C. DBA Ironwood Cancer & Res. Ctr.
Learn More & Join Trial
Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP) PHASE2 The investigators hypothesize that survival of newly diagnosed DLBCL (diffu...
Show More Location
Stanford University
Learn More & Join Trial
Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial) PHASE2 This is a prospective, single-arm, multi-center, phase II clinical trial to...
Show More Location
Sun yat-sen university cancer center
Learn More & Join Trial
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) PHASE1 The purpose of this trial is to measure the safety and effectiveness of epc...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone rituximab and lenalidomide rituximab and bendamustine rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin gemcitabine and oxaliplatin Epcoritamab rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone Lenalidomide rituximab, ifosfamide, carboplatin, and etoposide phosphate Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Rituximab and Lenalidomide Epcoritamab Learn More & Join Trial
A Study to Compare the Efficacy and Safety of JHL1101 Versus Rituximab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) PHASE3 Approximately 500 subjects will be enrolled in this study. Subjects who mee...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial